Evaluating a multiplier model approach to burden estimation by estimating COVID-19 disease burden in Maryland, USA from April 2020-March 2021 and discussing international feasibility Öffentlichkeit

Rohraff, Dallas (Summer 2021)

Permanent URL: https://etd.library.emory.edu/concern/etds/s7526d84m?locale=de
Published

Abstract

Background: COVID-19 disease burden estimation is valuable to understand the true impact of the disease considering that reported COVID-19 case counts are likely to be an underreport of the true number of infections. There remains a need for a straightforward approach to COVID-19 disease burden estimation which can be utilized in a variety of settings.

Methods: We developed a multiplier model approach to estimate COVID-19 burden, which can be modified for use in local or international settings. Using data from the state of Maryland as an example, we evaluated the use of the COVID-19 disease burden multiplier model to estimate COVID-19 associated symptomatic cases, medically attended illnesses, hospitalizations, and deaths from April 2020-March 2021. As a comparison, we estimated excess deaths due to COVID-19 during this time frame using age-specific time-series regression models.

Results: The multiplier approach estimated a total of 615,495 symptomatic illnesses, 234,853 medically attended illnesses, 33,567 hospitalizations, and 9,662 deaths across all age groups in the state of Maryland from April 2020 to March 2021. Those aged <50 years contributed to a majority of the estimated symptomatic and medically attended illnesses, but most hospitalizations and deaths estimated were among those aged ≥50 years. The regression model estimated 8,173 COVID-19 attributable deaths in the same time frame in Maryland.

Discussion: The multiplier model estimated COVID-19 burden in the state of Maryland reasonably well with estimates that were greater than reported case counts and deaths, but less than CDC seroprevalence estimates. This method may prove valuable in local areas if a straightforward approach is desired and the available data sources are well understood. The multiplier model seems feasible to use in Albania and South Africa, but further studies will be needed to evaluate its efficacy in international settings.

Table of Contents

INTRODUCTION 1

METHODS 3

     Data Sources 3

     Analytic Methods 6

          Multiplier Approach to COVID-19 Burden Estimation 6

               Dynamic Susceptible Population 6

               Symptomatic Illnesses 7

               Medically Attended Illnesses 8

               Hospitalizations 9

               Deaths 10

          COVID-19 Time-series Excess Mortality Regression Model 11

RESULTS 12

     COVID-19 Burden Estimates 12

     COVID-19 Time-series Excess Mortality Regression Model 13

DISCUSSION 14

     International Feasibility 19

          Albania 21

          South Africa 23

     Study Summary and Impact 24

NOTES 26

TABLES 27

FIGURES 29

SUPPLEMENTAL FIGURES 32

REFERENCES 35

About this Master's Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Subfield / Discipline
Degree
Submission
Language
  • English
Research Field
Stichwort
Committee Chair / Thesis Advisor
Committee Members
Zuletzt geändert

Primary PDF

Thumbnail Title Date Uploaded Actions
Evaluating a multiplier model approach to burden estimation by estimating COVID-19 disease burden in Maryland, USA from April 2020-March 2021 and discussing international feasibility () 2021-08-05 13:50:01 -0400

Supplemental Files

Thumbnail Title Date Uploaded Actions